IvyGate Consulting Firm (Beijing)

About Us: Founded in 2013, Ivy Gate is a consulting and distribution company specializing in the medical device and life science industries. Due to our strong connections with Chinese government departments and comprehensive sales network, we provide turn-key solutions for Western medical device & In-vitro Diagnostic companies with CFDA regulatory and commercialization service in China. We have accelerated many Western MedTech companies entry into China's market. Opportunities for foreign medical companies:  With increasing government spending on healthcare services and medical facilities and increased living standards, the medical device industry in China is projected to grow 15%-20% over the next five years. ■ The Chinese government also announced a desire to maintain the zero-tariff policy on imports of cancer drugs ■ In February 2018, the government announced the Hainan Free Trade Area policy for foreign hospitals entering into Hainan, as well as further measures to simplify the administrative process for medical device registration. ■ The Chinese government enhances IP protection for foreign medical companies. Our Four Main Services: 1. CFDA Registration  Shorten your time to market with a jump start on CFDA even before your FDA approval  Shorten your time to market, increase your revenue multiples.  China medical device/IVD regulations are complex. We help western companies by offering pre-market submission, post-market surveillance and green pathway CFDA approval.  Clinical Evaluation Reports and Clinical trials support. 2. Distribution: ■ Providing a comprehensive sales network across the entirety of mainland China. ■ Helping essential medical devices and drugs enter into both the Chinese medical insurance system and Chinese commercial insurance systems for reimbursement. ■ Based on National Health Commission policy, we provide distribution channels to hospitals of required medical equipment. 3. Capital: ■ Provide total-solution fundraising for high-end medical equipment for hospitals rental and lease services. ■ Introduce foreign companies to venture capital investors as well as provide partnering activities ■ M&A opportunities 4. Government Relations: ■ Government funding support ■ Government policy consulting services. ■ Legal support for Intellectual Property protection. ■ Policy guidance and support for setting up Wholly Owned medical manufacturers or Joint-Venture manufacturers. Future Strategy: We will focus on introducing innovative medical device and drugs into the Chinese market to provide patients with quality products and services. We look forward to cooperating with more foreign companies and distributing their products and jointly improving and expanding the sales performance and popularity of products in China so as to achieve a strategic partnership of mutual benefit.

• Employees 0
• Founded 2010